UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial

Journal of vascular surgery, 2010, Vol.52 (4), p.825-833.e2

2010

Volltextzugriff (PDF)

Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: An analysis of the PROactive study population

International journal of cardiology, 2012-12, Vol.162 (1), p.20-26

2012

Volltextzugriff (PDF)

An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: A supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): The TASC steering committee

Catheterization and cardiovascular interventions, 2015-10, Vol.86 (4), p.611-625

2015

Volltextzugriff (PDF)

The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study

Journal of the American College of Cardiology, 2007-05, Vol.49 (17), p.1772-1780

2007

Volltextzugriff (PDF)

Pioglitazone Use and Heart Failure in Patients With Type 2 Diabetes and Preexisting Cardiovascular Disease: Data from the PROactive Study (PROactive 08)

Diabetes care, 2007-11, Vol.30 (11), p.2773-2778

2007

Volltextzugriff (PDF)

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

Vascular medicine (London, England), 2015-10, Vol.20 (5), p.465-478

2015

Volltextzugriff (PDF)

Inter-society consensus for the management of peripheral arterial disease

International angiology, 2007-06, Vol.26 (2), p.81

2007

Volltextzugriff (PDF)

Pioglitazone and bladder cancer – Authors' reply

The Lancet (British edition), 2011, Vol.378 (9802), p.1544-1545

2011

Volltextzugriff (PDF)

Fåhraeus Award Lecture: The dangerous red cell

Clinical hemorheology and microcirculation, 2016-12, Vol.4 (2-3), p.115-132

2016

Volltextzugriff (PDF)

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

European journal of vascular and endovascular surgery, 2007-01, Vol.33 (1), p.S1-S75

2007

Volltextzugriff (PDF)

Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes

Journal of vascular surgery, 2007-05, Vol.45 (5), p.953-961

2007

Volltextzugriff (PDF)

Report on Second European Conference on Clinical Hemorheology

Clinical hemorheology and microcirculation, 2016-12, Vol.1 (5-6), p.411-413

Dormandy, John A.

2016

Volltextzugriff (PDF)

Arpad Matrai

Clinical hemorheology and microcirculation, 2018-06, Vol.8 (5), p.569-570

2018

Volltextzugriff (PDF)

Effects of Pioglitazone in patients with type 2 diabetes with or without previous stroke results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04)

Stroke (1970), 2007-03, Vol.38 (3), p.865-873

2007

Volltextzugriff (PDF)

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

Annals of Vascular Diseases, 2015, Vol.8(4), pp.343-357

2015

Volltextzugriff (PDF)

PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study

Vascular health and risk management, 2007, Vol.3 (4), p.355-370

2007

Volltextzugriff (PDF)

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

Journal of endovascular therapy, 2015-10, Vol.22 (5), p.663-677

2015

Volltextzugriff (PDF)

Importance of red cell aggregation in venous pathology

Clinical hemorheology and microcirculation, 2016-12, Vol.7 (1), p.119-122

2016

Volltextzugriff (PDF)

The prospective pioglitazone Clinical Trial in macrovascular Events (PROactive): Can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5,238 patients

Diabetes care, 2004-07, Vol.27 (7), p.1647-1653

2004

Volltextzugriff (PDF)

Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes: An Overview of Data from PROactive

Drug safety, 2009-01, Vol.32 (3), p.187-202

2009

Volltextzugriff (PDF)

Transatlantic Conference on Clinical Trial Guidelines in Peripheral Arterial Disease: Clinical Trial Methodology

Circulation (New York, N.Y.), 1999-10, Vol.100 (17)

1999

Volltextzugriff (PDF)

Reply

Journal of vascular surgery, 2011-05, Vol.53 (5), p.1454

2011

Volltextzugriff (PDF)

Leukocytes and the risk of ischemic diseases

JAMA : the journal of the American Medical Association, 1987-05, Vol.257 (17), p.2318

1987

Volltextzugriff (PDF)

Therapeutic angiogenesis for critical limb ischemia: design of the hepatocyte growth factor therapeutic angiogenesis clinical trial

Vascular medicine (London, England), 2004-08, Vol.9 (3), p.193-198

2004

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Englisch
(104)
Japanisch
(2)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial

Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: An analysis of the PROactive study population

An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: A supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): The TASC steering committee

The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study

Pioglitazone Use and Heart Failure in Patients With Type 2 Diabetes and Preexisting Cardiovascular Disease: Data from the PROactive Study (PROactive 08)

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

Inter-society consensus for the management of peripheral arterial disease

Pioglitazone and bladder cancer – Authors' reply

Fåhraeus Award Lecture: The dangerous red cell

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes

Report on Second European Conference on Clinical Hemorheology

Arpad Matrai

Effects of Pioglitazone in patients with type 2 diabetes with or without previous stroke results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04)

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

Importance of red cell aggregation in venous pathology

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

The prospective pioglitazone Clinical Trial in macrovascular Events (PROactive): Can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5,238 patients

Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes: An Overview of Data from PROactive

Transatlantic Conference on Clinical Trial Guidelines in Peripheral Arterial Disease: Clinical Trial Methodology

Reply

Leukocytes and the risk of ischemic diseases

Therapeutic angiogenesis for critical limb ischemia: design of the hepatocyte growth factor therapeutic angiogenesis clinical trial

Suchergebnisse filtern